Skip to Main content Skip to Navigation
Journal articles

Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease.

Abstract : BACKGROUND: Inflammatory bowel disease constitutes a heterogeneous group of conditions, whose aetiology is only partly understood. The prevailing hypothesis on its pathogenesis is that IBD is the result of an inadequate immune response to the resident bacterial flora of the intestine. An autoimmune background, however, has been discussed since the 1950s. Lately, it has been shown that failures in interleukin-10 (IL-10) signalling due to IL-10- and IL-10 receptor (IL-10R) mutations result in IBD. Our study aimed at investigating the existence of inhibitory autoantibodies against IL-10 and IL-10R in IBD patients capable of down-modulating IL-10 signalling thereby mimicking IL-10 or IL-10R deficiency. RESULTS: Thirteen IBD patients had IgG autoantibodies against IL-10, IL-10RA and/or IL-10RB, and three patients had IgA autoantibodies against IL-10. However, the absolute OD values of the serum antibodies measured by ELISA were low, there was overall no significant difference between patients and controls, and positive sera had no neutralizing activity. CONCLUSION: No evidence for an involvement of autoantibodies against IL-10 or IL-10R in the pathogenesis of inflammatory bowel disease could be established.
Document type :
Journal articles
Complete list of metadatas

Cited literature [30 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00955829
Contributor : Ed. Bmc <>
Submitted on : Wednesday, March 5, 2014 - 1:07:09 PM
Last modification on : Friday, March 27, 2020 - 2:25:38 AM
Long-term archiving on: : Thursday, June 5, 2014 - 11:20:57 AM

Files

Identifiers

Collections

Citation

Natalie Frede, Erik-Oliver Glocker, Jennifer Wanders, Karin Engelhardt, Wolfgang Kreisel, et al.. Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease.. BMC Immunology, BioMed Central, 2014, 15 (1), pp.10. ⟨10.1186/1471-2172-15-10⟩. ⟨inserm-00955829⟩

Share

Metrics

Record views

1637

Files downloads

1331